Researchers William Scott, Martin O’Donnell and Geno Samaritoni have developed IUPUI’s Distributed Drug Discovery, or D3, program to discover treatments for neglected diseases. Its newest partnership with the University of Havana brings its total of global collaborators to seven.
Scott, O’Donnell and Samaritoni have contacted technology transfer personnel at Indiana University Research and Technology Corp. to protect the compounds they have developed under D3. IURTC protects, markets and licenses intellectual property developed at Indiana University so it can be commercialized by industry
More information about the D3 program’s partnership with the University of Havana is available here.
Leave a Reply